BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

852 related articles for article (PubMed ID: 17909448)

  • 1. Treatment of Ménière's disease by low-dosage intratympanic gentamicin application: effect on otolith function.
    Helling K; Schönfeld U; Clarke AH
    Laryngoscope; 2007 Dec; 117(12):2244-50. PubMed ID: 17909448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliability of the vestibular evoked myogenic potential test in assessing intratympanic gentamicin therapy in Meniere's disease.
    Ozluoglu LN; Akkuzu G; Ozgirgin N; Tarhan E
    Acta Otolaryngol; 2008 Apr; 128(4):422-6. PubMed ID: 18368577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intentional ablation of vestibular function using commercially available topical gentamicin-betamethasone eardrops in patients with Meniere's disease: further evidence for topical eardrop ototoxicity.
    Kaplan DM; Hehar SS; Bance ML; Rutka JA
    Laryngoscope; 2002 Apr; 112(4):689-95. PubMed ID: 12150525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratympanic gentamicin for intractable Meniere's disease.
    Perez N; Martín E; García-Tapia R
    Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-shot, low-dose intratympanic gentamicin in Ménière disease: role of vestibular-evoked myogenic potentials and caloric test in the prediction of outcome.
    Gode S; Celebisoy N; Akyuz A; Gulec F; Karapolat H; Bilgen C; Kirazli T
    Am J Otolaryngol; 2011; 32(5):412-6. PubMed ID: 20851502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC; Minor LB
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEMPs and dynamic posturography after intratympanic gentamycin in Menière's disease.
    Picciotti PM; Fiorita A; Di Nardo W; Quaranta N; Paludetti G; Maurizi M
    J Vestib Res; 2005; 15(3):161-8. PubMed ID: 16179764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of unilateral isolated utricular hypofunction.
    Schönfeld U; Helling K; Clarke AH
    Acta Otolaryngol; 2010 Jun; 130(6):702-7. PubMed ID: 20082563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does intratympanic gentamicin treatment for Meniere's disease cause complete vestibular ablation?
    Hone SW; Nedzelski J; Chen J
    J Otolaryngol; 2000 Apr; 29(2):83-7. PubMed ID: 10819105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term results after interval therapy with intratympanic gentamicin for Menière's disease.
    Lange G; Maurer J; Mann W
    Laryngoscope; 2004 Jan; 114(1):102-5. PubMed ID: 14710003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transtympanic gentamicin and fibrin tissue adhesive for treatment of unilateral Menière's disease: effects on vestibular function.
    Casani A; Nuti D; Franceschini SS; Gaudini E; Dallan I
    Otolaryngol Head Neck Surg; 2005 Dec; 133(6):929-35. PubMed ID: 16360516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intratympanic application of aminoglycosides on click-evoked myogenic potentials in Guinea pigs.
    Day AS; Lue JH; Yang TH; Young YH
    Ear Hear; 2007 Feb; 28(1):18-25. PubMed ID: 17204896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term disability of class A patients with Ménière's disease after treatment with intratympanic gentamicin.
    Boleas-Aguirre MS; Sánchez-Ferrandiz N; Guillén-Grima F; Perez N
    Laryngoscope; 2007 Aug; 117(8):1474-81. PubMed ID: 17607149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intratympanic gentamicin treatment for intractable Menière's disease].
    Gilony D; Wolf M; Kronenberg J
    Harefuah; 2004 Jan; 143(1):4-7, 88. PubMed ID: 14748278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratympanic gentamicin for the treatment of Meniere's disease and other forms of peripheral vertigo.
    Carey J
    Otolaryngol Clin North Am; 2004 Oct; 37(5):1075-90. PubMed ID: 15474112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vestibular function at the end of intratympanic gentamicin treatment of patients with Ménière's disease.
    Perez N; Rama-Lopez J
    J Vestib Res; 2005; 15(1):49-58. PubMed ID: 15908740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subjective visual vertical in acute attacks of Ménière's disease.
    Kumagami H; Sainoo Y; Fujiyama D; Baba A; Oku R; Takasaki K; Shigeno K; Takahashi H
    Otol Neurotol; 2009 Feb; 30(2):206-9. PubMed ID: 19092712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Ménière's disease by intratympanic gentamicin application.
    Assimakopoulos D; Patrikakos G
    J Laryngol Otol; 2003 Jan; 117(1):10-6. PubMed ID: 12590850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saccular dysfunction in Meniere's disease.
    de Waele C; Huy PT; Diard JP; Freyss G; Vidal PP
    Am J Otol; 1999 Mar; 20(2):223-32. PubMed ID: 10100527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratympanic gentamicin therapy for intractable Ménière's disease.
    De Beer L; Stokroos R; Kingma H
    Acta Otolaryngol; 2007 Jun; 127(6):605-12. PubMed ID: 17503229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.